ABC transporters mediate the efflux of anti-cancer drugs and are critically involved in multidrug resistance [21, 49–51]; the expression of ABC transporters is up-regulated in patients after neoadjuvant therapy [52]. This evidence concerns the gene ABCG2 and cancer.